Overview

An Open, Single-center Study to Determine the Antibody Repsonse to Gastrimmune and Its Safety and Tolerability in Patients With Advanced Pancreatic Carcinoma

Status:
Completed

Trial end date:
2002-02-01

Target enrollment:

Participant gender:

Summary

This study was designed to determine the effect of jaundice on the ability of G17DT to generate antibodies before and after treatment of biliary obstruction due to advanced pancreatic cancer.

Phase:

Phase 2

Details

Lead Sponsor:

Cancer Advances Inc.

Treatments:

Antibodies